Delisting Determination,The Nasdaq Stock Market, LLC,
March 12, 2019, Organogenesis Holdings Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the warrant of Organogenesis Holdings Inc.
(the Company), effective at the opening of the trading
session on March 22, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5560(a) and 5225(b)(1)(A).
The Company was notified
of the Staffs determination on November 2, 2018.
The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
January 4, 2019, granting the Company continued listing
pursuant to an exception that included several milestones
that the Company was required to meet, towards the goal
of regaining compliance with Listing Rules 5560(a) and 5225(b)(1)(A).
The Company did not appeal the Staff determination to the
Hearings Panel, and the Staff determination to delist the
warrant became final on January 8, 2019.